Christos Coutifaris
Directeur/Membre du Conseil chez American Society for Reproductive Medicine
Profil
Christos Coutifaris is a Member of the Board of Directors at the American Society for Reproductive Medicine.
He was previously a Member of the Clinical Advisory Board at Nora Therapeutics, Inc.
Postes actifs de Christos Coutifaris
| Sociétés | Poste | Début |
|---|---|---|
American Society for Reproductive Medicine
 American Society for Reproductive Medicine Miscellaneous Commercial ServicesCommercial Services The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar. | Directeur/Membre du Conseil | - |
Anciens postes connus de Christos Coutifaris
| Sociétés | Poste | Fin |
|---|---|---|
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
American Society for Reproductive Medicine
American Society for Reproductive Medicine Miscellaneous Commercial ServicesCommercial Services The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar. | Commercial Services |
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Health Technology |
